Pex5p is the receptor for the peroxisomal targeting signal 1 (PTS1) that consists of a C-terminal tripeptide (consensus (S/A/C)(K/R/H)(L/M)). Hexadecapeptides recognized by Pex5p from Homo sapiens and Saccharomyces cerevisiae were identified by screening a two-hybrid peptide library, and the targeting ability of the peptides was demonstrated using the green fluorescent protein as reporter. The PTS1 receptors recognized in a speciesspecific manner a broad range of C-terminal tripeptides, and these are reported herein. In addition, residues upstream of the tripeptide influenced the strength of the interaction in the two-hybrid system as well as in an in vitro competition assay. In peptides interacting with the human protein, hydrophobic residues were found with high frequency especially at positions ؊2 and ؊5, whereas peptides interacting with S. cerevisiae Pex5p were more hydrophilic and frequently contained arginine at position ؊2. In instances where the terminal tripeptide deviated from the consensus, upstream residues exerted a greater influence on the ability of the hexadecapeptides to bind Pex5p.
Pex5p is the receptor for the peroxisomal targeting signal 1 (PTS1) that consists of a C-terminal tripeptide (consensus (S/A/C)(K/R/H)(L/M)). Hexadecapeptides recognized by Pex5p from
Homo sapiens and Saccharomyces cerevisiae were identified by screening a two-hybrid peptide library, and the targeting ability of the peptides was demonstrated using the green fluorescent protein as reporter. The PTS1 receptors recognized in a speciesspecific manner a broad range of C-terminal tripeptides, and these are reported herein. In addition, residues upstream of the tripeptide influenced the strength of the interaction in the two-hybrid system as well as in an in vitro competition assay. In peptides interacting with the human protein, hydrophobic residues were found with high frequency especially at positions ؊2 and ؊5, whereas peptides interacting with S. cerevisiae Pex5p were more hydrophilic and frequently contained arginine at position ؊2. In instances where the terminal tripeptide deviated from the consensus, upstream residues exerted a greater influence on the ability of the hexadecapeptides to bind Pex5p.
Compartmentalization of metabolic processes in eukaryotic cells requires that participating enzymes be transported to their correct subcellular location. Proteins destined to the peroxisomal matrix are imported from the cytosol (1) in a process involving specific targeting signals within the primary structure. So far, two different signals that are sufficient for transporting proteins to the peroxisomal matrix have been defined: a C-terminal peroxisomal targeting signal 1 (PTS1) 1 that is present in the majority of peroxisomal matrix proteins and first identified in luciferase, and a PTS2 that is usually located within the N-terminal 30 amino acids of some peroxisomal proteins (Refs. 2 and 3; for reviews, see Refs. 4 and 5) . PTS1 consists of a tripeptide located at the C terminus that is characterized by the sequence SKL or conservative variants ((S/A/C)(K/R/H)(L/M)), whereas PTS2 fits the loose (R/K)(L/V/ I)X 5 (Q/H)(L/A) consensus sequence (6) . Recognition of peroxisomal targeting signals by specific receptor proteins initiates a series of steps that lead to translocation of the proteins into the peroxisomal matrix. PTS1-carrying proteins are recognized by the receptor Pex5p (7) (8) (9) (10) (11) (12) , which in Saccharomyces cerevisiae is mainly cytosolic (13) . The intracellular location of the human protein is less clear, having been described as associated with peroxisomes or mainly cytosolic (14) . It is likely that the major portion of Pex5p is cytosolic, while a minor one is bound to the peroxisomal membrane through interaction with Pex13p (15) . Both the human and yeast Pex5p interact with PTS1 via the C-terminal half of the protein, which is composed of a tetratricopeptide repeat (TPR) domain formed by seven repeats (9, 16) .
Although PTS1 is conserved throughout evolution (17) , its consensus in lower eukaryotes was thought to be broader than in mammals (5, 18, 19) . PTS1 variants such as SKF or SKI direct catalases to peroxisomes of S. cerevisiae and Hansenula polymorpha, respectively (20, 21) ; however, similarly extended luciferases do not reach peroxisomes in monkey kidney cells (22) . Other examples of C-terminal tripeptides that target peroxisomal proteins in S. cerevisiae (malate dehydrogenase 3; Ref. 23 ) but fail to direct luciferase to peroxisomes of monkey kidney cells are EKL, FKL, and SKV (22) . PTS1 was originally defined in mammalian cells using various tripeptides extending from heterologous reporter proteins. Peroxisomal matrix proteins, on the other hand, may be directed to the organelle via C-terminal tripeptides that do not match the original consensus. SQL, KKL, SSL, or NKL target alanine/glyoxylate aminotransferase 1 to peroxisomes in human cells (24) , and SQL of the rat pristanoyl-CoA oxidase interacts with Homo sapiens Pex5p (25) . Hence, it remains unclear why a particular tripeptide not matching the PTS1 consensus succeeds in directing to peroxisomes selected proteins in some organisms but not in others. This may be due to the requirement by the PTS1 receptor (Pex5p) for particular features or neighboring amino acids (26) that could differ between species; however, other components of the import machinery may also be responsible for such differences.
To investigate which C-terminal sequences are recognized by Pex5p and whether there are differences between the human and yeast PTS1 receptors, we performed a two-hybrid screen (27) using a peptide library that encodes the activation domain of Gal4p extended at the C terminus by random 16-mer peptides (28) , and a detailed analysis of amino acid sequences recognized by the S. cerevisiae or the human Pex5p is presented. Of the different peptides recognized by the two receptors, a number were tested for their ability to target green 
-terminal peptides interacting with S. cerevisiae Pex5p in the two-hybrid screen
The C-terminal half of S. cerevisiae Pex5p containing the TPR domain encoded by plasmids pAH987 was used to screen a two-hybrid peptide library consisting of 16 NN(T/G) codons fused to the Gal4p activation domain (28) . Peptides with fewer than 16 residues arose due to premature termination as a result of stop codons. The C-terminal tripeptides are indicated in boldface type, consensus (6) 
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TABLE II C-terminal peptides interacting with human Pex5p in the two-hybrid screen
The C-terminal half of human Pex5p containing the TPR domain encoded by plasmid hP87 was used to screen a two-hybrid peptide library consisting of 16 NN(T/G) codons fused to the Gal4p activation domain (28) . Peptides with fewer than 16 residues arose due to premature termination as a result of stop codons. The C-terminal tripeptides are indicated in boldface type, consensus (6) endings are depicted in the left columns, and nonconsensus endings are on the right.
Peptide
Sequence Peptide Sequence
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LGPLFSML 32) . Yeast transformants were selected and grown on minimal medium containing 0.67% yeast nitrogen base without amino acids (Difco), 2% glucose and supplemented with bases and amino acids (20 -150 g/ml) as required (SC-ura or SC-leu-trp). For fluorescence microscopy, transformed wild type yeast cells (CB80) were grown at 30°C with shaking in selective media with 0.5% glucose as sole carbon source until the glucose concentration was very low (ϳ0.05%, usually 12-16 h), harvested by centrifugation, and resuspended in twice the original volume of induction medium containing 30 mM potassium phosphate, pH 6.0, 0.3% yeast extract, 0.5% peptone, and 0.2% oleate (adjusted to pH 7.0 with NaOH) and 0.02% Tween 80. For fluorescence microscopy, transformed pex5 mutant cells (CB82) were grown in selective media with 2% ethanol as sole carbon source. For quantitative measurement of ␤-galactosidase activity, yeast cells were grown at 30°C with shaking in selective medium (2% glucose) overnight, diluted to A 600 ϭ 0.3 into the same medium, and finally harvested at A 600 ϭ 1.
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MKLRMVVRMNPLKCVL
Hs27
RVCWNGIEQGKKWARL
Hs28
SGNLCWRDLPQMIARL
Hs29
SRNEAILGGEYTMARL
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Hs31
WRIVSPYTGGSLSCKL
Hs32
FMYAMQIEHSLPFCRL
Hs33
RDGELVPLYHLIPCRL
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SKVFVSGWGAGGMSRM
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RWLYVWREGWGVRARM
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IVVVPLTPRCILICRM
Hs38
ATSQDWAGLPLRSHL
Hs39
ACGSKEEWPWGYRAHM
Cloning Procedures-Standard procedures were used for cloning (33) . Linear fragments were isolated from the agarose gels as described (34) . Restriction enzymes were obtained from Boehringer Mannheim (Vienna, Austria) and used as recommended. Double strand sequencing was performed using the T7 sequencing kit from Amersham Pharmacia Biotech. Oligonucleotides were purchased from the Institute for Microbiology and Genetics, University of Vienna, Austria. For PCR, DynaZyme TM DNA polymerase from FINNZYMES OY (Espoo, Finland) or Pfu DNA polymerase (Stratagene, La Jolla, CA) was used.
The 900-bp BamHI-PstI fragment from plasmid pAH957 (16) was cloned into pGBT9 (35) , resulting in plasmid pAH987, which encodes the binding domain of Gal4p fused to the TPR domain of S. cerevisiae Pex5p (amino acids 307-612). Plasmid hP87 (TPR domain of human Pex5, amino acids 331-639) was constructed by ligating to an EcoRISalI-digested pGBT9 a 1-kilobase pair EcoRI-SalI-digested PCR fragment obtained using oligonucleotides H284 and H314 with pPTS1-BP (9) as template.
Plasmid pJR233 (designated GFP-SKL; Ref. 32) codes for a modified version of the green fluorescent protein of Aequoria victorea terminating in the PTS1 SKL (36) under control of the MLS1 promoter (37) in plasmid YEp352 (38) . For in frame cloning of DNA sequences coding for PTS1 peptides isolated in the two-hybrid screen, a BamHI restriction site was introduced at the 3Ј-end of the open reading frame of the GFP, removing the PTS1 codons, and the BamHI site close to the start of the open reading frame was simultaneously destroyed using PCR (oligonucleotides H336, H337, and template pJR233). After inserting the 800-bp KpnI-PstI-digested PCR fragment in pUC18 (39), the KpnI-HindIII fragment of 800 bp was used to replace the KpnI-HindIII fragment from pJR233, resulting in plasmid 233M. Selected sequences coding for interacting C-terminal endings were isolated from the corresponding library plasmids based on pGAD.GH (28) as BamHI-HindIII fragments (80 bp) and subsequently cloned into 233M, creating GFP-fusion proteins with different C termini. The sequence coding for K01 (WARGGS-GDGGWAYCFC) was obtained from an additional 80-bp BamHIHindIII insert in one of the isolated library plasmids. Likewise, for in vivo import experiments in human cells, the pEGFP-C3 vector (CLON-TECH, Palo Alto, CA) was used for construction of GFP fusion proteins with various C termini by cloning the 80-bp BamHI-HindIII fragments into the BglII-HindIII-digested plasmid.
The oligonucleotides used were H284 (CAAAGATCTGTCGACTCA-CTGGGGCAGGCC), H313 (TACCACTACAATGGATG), H314 (CACA-TGAATTCAACCCCTTGCGTGATCAC), H336 (GAAAATGGGTACCC-GGGGGTCCAGTAAAGGAGAAG), and H337 (CATGCCTGCAGGCTC-TGGATCCTTGGATAGTTCATC).
Two-hybrid Experiments-According to the Matchmaker two-hybrid system protocol (CLONTECH), yeast strain PCY3 was transformed
TABLE III Amino acid distribution of the C-terminal 11 positions of peptides longer than 3 residues interacting with S. cerevisiae Pex5p
The frequencies observed were compared with the ones expected in a library consisting of 16 repeats of the codon NN(T/G) (28) . Assuming binominal distribution, the expected values are 9.7% for amino acids with three possible codons (L, R, S), 6.5% for amino acids with two possible codons (A, G, P, T, V), and 3.2% for amino acids with one possible codon (C, D, E, F, H, I, K, M, N, Q, Y, W). Applying standard statistical analysis (Windows EXCEL), deviations from these expected values were regarded as significant (indicated in boldface type) if the probability of the observed frequency was less than 2%.
TABLE IV Amino acid distribution of the C-terminal 11 positions of peptides longer than 3 residues interacting with human Pex5p
The frequencies observed were compared with the ones expected in a library consisting of 16 repeats of the codon NN(T/G) (28) . Assuming binominal distribution, the expected values are 9.7% for amino acids with three possible codons (L, R, S), 6.5% for amino acids with two possible codons (A, G, P, T, V), and 3.2% for amino acids with one possible codon (C, D, E, F, H, I, K, M, N, Q, Y, W). Applying standard statistical analysis (Windows EXCEL), deviations from these expected values were regarded as significant (indicated in boldface type) if the probability of the observed frequency was less than 2%. N  3  2  2  2  3  1  1  3  Q  3  1  2  1  1  3  1  2  2 successively with pAH987 or hP87 as well as a two-hybrid peptide library (kindly provided by S. Fields), which consisted of 16 NN(T/G) codons fused to the activation domain of the Gal4 protein (28) . Transformants were grown on selective minimal medium (SC-leu-trp), and replica-plated onto selective medium containing 5-bromo-4-chloro-3-indolyl-␤-galactopyranoside (X-gal). Blue colonies were restreaked onto the same medium, and library plasmids from blue single colonies were isolated and used to transform cells of PCY3 harboring plasmid pAH987 or hP87. ␤-Galactosidase activity was tested using filter assays following the Matchmaker protocol, and plasmids from colonies that turned blue in less than 3 h were isolated and amplified in E. coli. The short inserts were sequenced using oligonucleotide primer H313. For determination of ␤-galactosidase activities, yeast cells were harvested, washed with distilled water, and broken with glass beads. Cell debris was removed by centrifugation, and the protein concentration of the supernatant was determined (40) . ␤-Galactosidase activities were measured photometrically at 420 nm using the substrate o-nitrophenyl ␤-D-galactopyranoside as described (41) . Two transformants harboring each of the respective plasmids were tested in duplicate, and the ␤-galactosidase activities presented here were the average of four determinations (S.D. was less than 15%). The units were defined as nmol of o-nitrophenyl ␤-D-galactopyranoside hydrolyzed per min (41) .
Cultivation and Transfection of Human Cells-HeLa cells were grown on tissue culture chamber slides (Nunc, Roskilde, Denmark) in Dulbecco's modified Eagle's medium supplemented with fetal calf serum (10%) and 2 mM L-glutamine plus penicillin, streptomycin, and fungizone in a humidified atmosphere containing 10% CO 2 . Primary cultured human fibroblasts obtained from a healthy patient were grown in RPMI (1640 medium supplemented with fetal calf serum (10%) and 2 mM L-glutamine plus penicillin, streptomycin, and fungizone). Transfections were performed using DEAE-dextran (Amersham Pharmacia Biotech) according to standard protocols (42) with either 0.5 g or 1.5 g of the selected pEGFP plasmids constructed. Cells were used directly for fluorescence microscopy 48 h after transfection or were processed for immunofluorescence as described by Keller et Other Methods-In vitro peptide binding experiments were performed in wells of microtiter plates coated overnight in 50 mM sodium carbonate buffer, pH 9.6, with 1 g of HSA-SKL obtained by crosslinking human serum albumin to the peptide pSKL. The biotinylated human Pex5 fusion protein (amino acids 258 -639) encoded by the Pinpoint Xa1 vector (Promega) containing the 1.15-kilobase pair cDNA insert from plasmid PTS1-BP (9) was isolated as described previously (46) . Competition between the immobilized HSA-SKL and free peptide for binding to the PTS1 receptor was assayed by adding different concentrations of peptides to the microtiter wells simultaneously with 5 l of isolated PTS1 receptor. The fraction of the PTS1 receptor bound via HSA-SKL was determined as described (9) . Peptides pSKL (CSYH-KHLKPLQSKL) and pUNSKL (CVHESYHKHLKPLQ) were described previously (9); peptides Sc02 (SHRRMDATKRRESKL), Hs55 (GGRRG-MGFPAVRSLL), and Hs57 (EYSRGGQGTMWRSLL) were purchased from the Institute for Molecular Pathology (Vienna, Austria).
Protein extracts from yeast cells were prepared as described (47) 
RESULTS
Peptides
Interacting with Pex5p-To identify C termini with PTS1 function, a two-hybrid peptide library (28) was screened for peptides interacting with the PTS1 receptors from H. sapiens and S. cerevisiae. Fusion proteins containing the yeast Pex5p TPR domain (sufficient for PTS1 binding; Ref. 16) or that of the human Pex5p were expressed from plasmids pAH987 and hP87, respectively. Plasmids from colonies that had turned blue within 24 h on plates containing 5-bromo-4-chloro-3-indolyl-␤-galactopyranoside were isolated, verified, and sequenced. The amino acid sequences extending the activation domain of Gal4p in the library plasmids were deduced, and a list of the peptides that interacted with the TPR domain of the respective Pex5p is shown in Tables I and II. To determine whether particular amino acids were overrepresented in the peptides that were recognized by either the yeast or the human Pex5p, their frequency at each position was determined. Within the peptides that were recovered using the yeast Pex5p (Table III) , the ultimate position of PTS1 was almost exclusively filled with leucine, the penultimate one with basic residues, while the first displayed a high degeneracy. Those peptides recognized by the human receptor (Table IV) similarly contained leucine at the ultimate position but differed at the penultimate one, where the consensus residues (K/R/H) could be substituted by polar (N/Q/S/Y) and nonpolar amino acids (L/M/A/V), and at the first position, where S/A/C/P/G was found.
Newly Identified PTS1 Variants Target Reporter Proteins to Peroxisomes-A number of these peptides were tested for PTS function in vivo using appropriately extended GFP. Localization of GFP-SKL (plasmid pJR233) to yeast peroxisomes, seen here as a punctate pattern using fluorescence microscopy, has been amply demonstrated before by immunoelectron microscopy (32, 48) and is shown using CB80 cells expressing GFP extended by the SKL-terminating peptide Sc02 (Fig. 1A) . Those cells expressing GFP-CFC (K01, which does not represent PTS1) gave rise to diffuse cytosolic staining (Fig. 1B) that resembled the staining with GFP-SKL in pex14 mutant cells, which lack functional peroxisomes (32) . Cells expressing GFP extended by Sc17, Sc18, Sc23, Sc31, or Sc33 (Fig. 1, C-G) LDN (pEGFP-C3, B) , SQL from Hs50 (C), SML from Hs52 (D), SLL from Hs55 (E), SLL from Hs57 (F), and CVL from Hs65 (G).
FIG. 2. Colocalization of GFP variants and peroxisomal thiolase in yeast cells. Wild-type yeast cells (CB80) expressing GFP extended by oligopeptides Sc02 (A, B) and Sc33 (D,
yielded a punctate fluorescence pattern that demonstrated the ability of these peptides terminating with CHL, AKM, TKL, PKL, or WKL, respectively, to target the otherwise cytosolic GFP to the peroxisomes. Immunostaining for the peroxisomal marker protein thiolase yielded identical punctation (Fig. 2, A,  B, D, and E) . This punctate pattern was absent in pex5 mutant cells (Fig. 2, C and F) , thus confirming the PTS1-dependent import of the GFP variants into peroxisomes.
Likewise, peptides identified in the screen using human Pex5p were examined for their ability to target enhanced GFP (EGFP; Ref. 49 ) to peroxisomes in human cells, where punctate and diffuse fluorescence patterns similarly correspond to peroxisomal and cytosolic location, respectively (50) . Punctate fluorescence was observed in transiently transfected HeLa cells expressing EGFP extended by peptide Hs04 harboring a Cterminal SKL (Fig. 3A) but not in those expressing unmodified EGFP (terminating in LDN; Fig. 3B ). Similar punctation was observed with Hs50, Hs52, Hs55, Hs57, and Hs65 (Fig. 3, C-G) at the C terminus of EGFP, and hence these (ending in SQL, SML, SLL, or CVL) acted as PTS1. Identical results were obtained using primary fibroblasts transiently transfected with the same plasmids (data not shown). Colocalization of GFP variants with peroxisomal catalase (Fig. 4, A-D) confirmed that the fluorescent dots represented peroxisomes.
Recognition of PTS1 Is Species-specific and Context-dependent-To examine the ability of peptides previously identified using S. cerevisiae Pex5p to interact with human Pex5p (and vice versa), a representative set of peptides ending with tripeptides other than the consensus was chosen for quantitative measurements of ␤-galactosidase activities in the twohybrid system (Table V) . Among 12 peptides that interacted with S. cerevisiae Pex5p, only four interacted with the human PTS1 receptor (terminating in AKF, HRL, YKL, and PKL; Table V, top). This indicated that Tyr and His at the first position, and Phe at the third, may occur in human PTS1s. Likewise, of 15 peptides that bound to the human Pex5p, only four interacted with the yeast receptor (ending with SML, SLL, ALL, and CLL; Table V, middle). Like the frequencies presented in Tables III and IV , these data implied that the two Pex5 proteins differed in their ability to interact with C-terminal tripeptides. The observation that of the four peptides terminating in SLL and recognized by the human Pex5p only one was capable of interacting with the yeast receptor indicated that in addition to attributing the difference in PTS1 recognition to the identity of the organism, binding of PTS1 also depended on the context of the 16-mer from which the signal was extended.
Upstream Residues Influence the Interaction between PTS1 and Pex5p-Closer examination of Table V revealed that despite ending in identical tripeptides, certain 16-mers were more efficient at interacting with the respective Pex5p than were others (cf. Hs55 versus Hs57, Hs50 versus Hs51; Table V ). This may have been due to differences in the amino acids adjacent to the terminal tripeptide. Therefore, the frequencies of each amino acid residue at the eight positions immediately upstream of the PTS1 were compared with the expected values (Tables III and IV) . Acidic residues were underrepresented at positions Ϫ1, Ϫ2, and Ϫ3 in both instances. In those peptides interacting with S. cerevisiae Pex5p, the basic residues lysine and arginine appeared at Ϫ1 and Ϫ2 more frequently than expected (Table III) . In peptides interacting with human Pex5p, on the other hand, a preference for basic residues was found only at position Ϫ1, and at the remaining positions, especially Ϫ2 and Ϫ5, an overrepresentation of hydrophobic residues such as valine and leucine was observed (Table IV) .
A more specific examination of the effects of neighboring residues on the efficiency of terminal tripeptides to interact with their respective receptor was conducted using canonical C termini (SKL and variants thereof; Table V, bottom). We observed that clusters of charged residues such as those present in peptides Sc02 and Sc17 were concomitant with a weak interaction with human Pex5p, whereas hydrophobic residues, e.g. in Hs04, coincided with poor binding to the yeast receptor.
Upstream Regions Influence in Vitro PTS1
Binding by Pex5p-To underscore the ability of the upstream region to modulate the interaction of PTS1 with the receptor in the absence of possible influences due to the conformation of the whole fusion protein, in vitro experiments using oligopeptides as competitors were performed. In these experiments, binding of biotinylated human Pex5p to immobilized PTS1 was competed by soluble oligopeptides (Fig. 5) . Two of the three synthetic 15-mers were designed after Hs55 and Hs57, since these SLL-terminating peptides displayed different levels of interaction in the two-hybrid system. The third synthetic 15-mer ending in SKL was designed after Sc02 that interacted poorly with human Pex5p. As controls, peptides pSKL (CSYHKHLK-PLQSKL) representing the C-terminal 13 amino acids of rat palmitoyl-CoA oxidase and its SKL-less derivative pUNSKL (CVHESYHKHLKPLQ) were used to illustrate the requirement of PTS1 to efficiently compete the binding of the receptor to the immobilized HSA-SKL as demonstrated previously (9) . Here, peptide Hs55 was approximately 3-fold more efficient than peptide Hs57 at competing for binding to Pex5p. Despite containing SKL, peptide Sc02 was not nearly as effective a competitor as the former two oligopeptides. These results fully concurred with those obtained using the two-hybrid system in demonstrating the ability of amino acid residues immediately upstream of PTS1 to modulate binding to the Pex5 protein.
DISCUSSION
In this study, the recognition of C-terminal peptides by the PTS1 receptor Pex5p was analyzed in detail. Using a twohybrid library encoding random hexadecapeptides (28), we identified an array of C-terminal endings, some of them significantly deviating from the canonical PTS1, that interacted with the TPR domain of the human and yeast Pex5p (7, 9) . The yeast TPR domain has previously been demonstrated to be sufficient for the interaction with PTS1 (16), and it is 39% identical with the domain in the human Pex5p (10) . The ability of the peptides identified through two-hybrid interactions to act as PTS1 was shown in vivo using the GFP reporter protein (Figs. 1 and 3) . Indirect immunofluorescence staining of the peroxisomal matrix proteins catalase (Fig. 4) and thiolase (Fig. 2) corroborated that peroxisomal import is reflected by the punctate fluorescence seen in human and wild type yeast cells expressing GFP-PTS1, respectively.
At the third and ultimate position of the terminal tripeptide, Leu was the most prevalent amino acid. In addition, Met and Phe, known to substitute for Leu in some cases, were also found (5, 20) ; however, peptides ending in isoleucine such as SKI or AKI sufficient for targeting H. polymorpha catalase (21) or Candida tropicalis trifunctional enzyme (51), respectively, did not show up in our screen. This is probably due to poor interaction with isoleucine at the ultimate position, since a representative SKI peptide (Hs04, Leu replaced by Ile) yielded only low values of specific ␤-galactosidase activity and additionally failed to target GFP to peroxisomes (data not shown).
Among the peptides identified in our screening procedure with S. cerevisiae Pex5p (Table I) , many tripeptidyl endings were found that did not conform to the consensus described (5). These include GKL, TKL, LKL, and PKL, previously shown to target malate dehydrogenase 3 to peroxisomes of S. cerevisiae (23) , and CNL, QKL, HRL, FRL, VKL, YKL, WKL, and WRL, not yet demonstrated to function as PTS1 in yeast. Among the peptides identified by interaction with human Pex5p (Table II) , some contained novel PTS1 variants like GKL, GRL, PRL, PKM, CNL, PNL, SML, SLL, ALL, CLL, SYL, PSL, SAL, and CVL, and others harbored C-terminal endings shown previously to allocate native peroxisomal matrix proteins to the PTS1 import pathway: SQL and SSL at the C terminus of human alanine/glyoxylate aminotransferase 1 (24) ; SQL in rat pristanoyl-CoA oxidase (25) ; and ANL in human catalase (26) .
The data from the two-hybrid screen indicated that there existed a difference in the recognition of PTS1s by the yeast and human Pex5p (Tables III and IV) . We therefore examined the ability of one receptor to interact with peptides identified through their interaction with the other. Some of the novel tripeptides that were identified using the yeast receptor and that also interacted with the human one (Table V) bore similarities to putative and functional human PTSs (yeast YKL and HRL to human YRM and HRM, respectively; Ref. 52) . A number of nonclassical tripeptides recovered using the human receptor interacted with the yeast Pex5p (SML, CLL, ALL, and SLL; Table V) . Interestingly, despite their common termini, peptides ending with ALL, SLL, or SQL showed large differences in their ability to interact with a given receptor. This indicated that residues adjacent to the tripeptidyl terminus played a key role in influencing the ability of the terminus to act as a PTS1. Previous work demonstrated that in some instances PTS1s extend beyond the terminal tripeptide. DHFR-SKL is not imported into yeast peroxisomes; however, when extended by KNIESKL or GGKSKL, the reporter protein was compartmentalized in the organelle (20) . One possible explanation is that in the context of the structure of DHFR the SKL extension was not accessible to Pex5p, but by adding three or four residues the C terminus was now exposed. Alternatively, native residues at the C terminus of DHFR interfered with SKL, and by placing intervening amino acids this influence was obviated, allowing SKL to act as PTS1. The influence of residues adjacent to the PTS1 on its function was underscored by the finding that chloramphenicol acetyltransferase used as a reporter protein was only efficiently imported into peroxisomes when Lys or Arg preceded the terminal tripeptide ANL (26) . Therefore, we analyzed the frequencies of amino acids occurring upstream of PTS1 in oligopeptides that were identified in the two-hybrid screen (Tables III and IV) . There appeared to be a preference for Arg and Lys at position Ϫ1 for receptors from both organisms; however, at position Ϫ2 the preference for particular amino acids was even more pronounced and differed between the yeast and human receptor. The yeast receptor showed a preference for polar and hydrophilic residues, with an overrepresentation of the positively charged amino acid Arg at position Ϫ2 (Table III) . In the few instances where a negatively charged residue was found either there or at position Ϫ1 (Sc01, Sc02, Sc27, Sc29), it was invariably counteracted by neighboring positive charges (Table I ). In contrast, the human receptor displayed a preference for hydrophobic residues, especially at positions Ϫ2 and Ϫ5 (Table IV) . These species-specific preferences at position Ϫ2 were found independently of whether the tripeptidyl ending adhered to the consensus or not, although the preferences were slightly more pronounced for the nonconsensus endings (Tables I and II,  compare left and right columns) . Interestingly, at position Ϫ1, Arg and Lys were clearly preferred in peptides interacting with human Pex5p with nonconsensus endings (but not in peptides with consensus endings). Such differences in preferences at position Ϫ1 were not observed in peptides interacting with S. cerevisiae Pex5p. How do our findings correlate with PTS1s found in native peroxisomal proteins? The C termini of the few proteins previously localized to peroxisomes harboring either a potential or a proven PTS1 consist in most cases of SKL or variants (10 for S. cerevisiae, 19 for human cells; data from Swissprot (53)). In human peroxisomal proteins, a basic amino acid at position Ϫ1 and hydrophobic residues at positions Ϫ2 and Ϫ5 are preferred. In peroxisomal proteins of S. cerevisiae, on the other hand, no statistically significant preferences were found at any position.
We asked whether overrepresentation of amino acids at particular positions upstream of the terminal tripeptide correlated with the strength of interaction with the respective receptor. A direct relationship between the strength of interaction of a particular 16-mer with Pex5p and its amino acid composition was not found; however, what did emerge was that upstream residues influenced the ability of the terminal tripeptides to efficiently act as PTS1 (Table V) . To determine whether this influence was exerted in conjunction with the overall structure of the reporter protein, we conducted in vitro binding assays using oligopeptides (Fig. 5) . The varying efficiencies at competing with the immobilized PTS1 for Pex5p that were observed correlated with the ␤-galactosidase measurements. Hence, residues upstream of the terminal tripeptide are able and sufficient to influence the latter's function as PTS1 independently of the tertiary structure of the protein from which they extend.
These results shed new light on experiments previously conducted using reporter proteins from which the PTS1 consensus was derived (5) . In these, the efficiency at acting as PTS1 of various C-terminal endings may have been influenced by the reporter protein itself, such as luciferase (22) , malate dehydrogenase 3 (23) , alanine/glyoxylate aminotransferase 1, or chloramphenicol acetyltransferase (24, 26) . In contrast, the 16 codons of the two-hybrid peptide library generated at random the immediate context of the C terminus, thus enabling the identification of tripeptides that require distinct adjacent amino acids to act as PTS1. Considering the large number of PTS1 variants capable of binding to Pex5p or shown to function at the C terminus of native peroxisomal matrix proteins (23, 24) , we postulate that more noncanonical PTS1-extended peroxisomal proteins will be discovered. Residues adjacent to the tripeptidyl C terminus in a given protein may act as an auxiliary moiety in one organism but not necessarily in another, e.g. the residues upstream of SKL in Sc02 resulted in high activities using the yeast receptor but not the human one, whereas those in Hs04 had the inverse effect (Table V) . Obviously, in the case of the canonical SKL the adjacent amino acids play only a modulating role, but the importance of the upstream residues (9) was incubated in microtiter wells that were coated with 1 g of human serum albumin cross-linked to the peptide pSKL (HSA-SKL) in the presence of indicated amounts of peptides pSKL (q), pUNSKL (‚), Sc02 (SHRRMDATKRRESKL; Ⅺ), Hs55 (GGRRGMGFPAVRSLL; E), or Hs57 (EYSRGGQGTMWRSLL; ϫ). After extensive washings, bound Pex5p was detected photometrically with streptavidin-alkaline phosphatase using p-nitrophenyl phosphate as a substrate. Peptide pSKL competed efficiently for the binding of Pex5p to HSA-SKL, whereas the peptide pUNSKL lacking a PTS1 did not.
to act as auxiliary moieties for PTS function increases the further the tripeptide deviates from the SKL consensus, which is illustrated by the differences in interaction of peptides ending in SLL with the human and the yeast Pex5p (Table V) . The species differences observed for PTS1 recognition thus result from different requirements concerning amino acid residues at distinct positions adjacent to the terminal tripeptide for interaction with the Pex5p.
Recently, another conserved domain that interacts with the C termini of target proteins has been identified and named PDZ (PSD-95 DlgA ZO-1) (54) . Based on a three-dimensional structure analysis (55), a model was put forward, in which the PDZ domain primarily recognizes the C-terminal hydrophobic residue and the specificity of interaction is determined by the adjacent four amino acids (54) . A similar mechanism may apply for the interaction between the Pex5p TPR domain and the PTS1.
